|
Buffalo
Hump Seen in HIV-Associated Lipodystrophy Is Associated with Hyperinsulinemia
But Not Dyslipidemia
Accumulation
of dorsocervical fat, or a "buffalo
hump" (BH), is commonly reported in adults with
HIV-associated
lipodystrophy (HIVLD). The pathogenesis underlying
this aspect of a syndrome characterized by loss of subcutaneous
fat from other body sites is poorly understood.
Supported
by an NIH grant, researchers at multiple medical centers aimed to
identify risk factors for a BH in HIV-infected adults in cross-sectional
analyses of 2 HIV-infected ambulatory populations.
The
first group (Australian Lipodystrophy Prevalence Survey [APS]) consisted
of 1348 Australian HIV-infected adults (95% male) irrespective of
changes in body composition. The second group (Lipodystrophy Case
Definition [LDCD] study) comprised 417 subjects (83% male) with
at least 1 reported moderate or severe feature of HIVLD.
A
BH was reported in 24 (2%) APS subjects and 79 (19%) LDCD study
subjects. A BH was not an isolated finding.
Patients
with a BH had a high prevalence of other features of HIVLD, similar
to lipodystrophic patients without a BH, such as facial lipoatrophy
reported in 100% and 61% BH-positive subjects from the APS and LDCD
study, respectively.
In
both groups, those with a BH had higher fasting insulin (P <=
0.007), a higher body mass index (P <= 0.003), a higher waist/hip
ratio (P <= 0.001), higher limb fat (P <= 0.003), and higher
systolic blood pressure (P < 0.05).
On
multivariate analysis, higher serum insulin, systolic blood pressure,
age, and duration of exposure to ritonavir
(Norvir) were independently associated with a BH
in the APS group.
In
the LDCD group, higher insulin, diastolic blood pressure, and duration
of exposure to zidovudine
(Retrovir) were independently associated with a BH.
There
was no association between a BH and hyperlipidemia.
Conclusions
The
authors conclude, “These data show that a BH is associated with
other physical features of the lipodystrophy phenotype and suggest
that hyperinsulinemia, a feature common to HIVLD, obesity, and hypercortisolism,
is an important component of this phenotype, thus warranting closer
monitoring of BH-positive patients for glucose intolerance and diabetes.”
The
National Institute of Allergy and Infectious Diseases (NIAID), National
Institutes of Health, 5U01AI042170-10 and 5U01AI046362-03, provided
financial support for this study as part of the Flexible Initial
Retrovirus Suppressive Therapies (FIRST) study (CPCRA 058) and the
Metabolic Substudy of FIRST (CPCRA 061).
01/28/05
Reference
P
Mallon and others.
Buffalo Hump Seen in HIV-Associated Lipodystrophy is Associated
with Hyperinsulinemia But Not Dyslipidemia.
Journal of Acquired Immune Deficiency Syndromes 38(2):156-162,
February 1, 2005.
|